Stock Events

Stock Events

Adaptive Biotechnologies 

€11.86
125
+€0.1+0.89% Today

Statistics

Day High
11.86
Day Low
11.86
52W High
17.25
52W Low
6.81
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5AugExpected
Q4 2025
Q1 2026
Next
-0.16
-0.13
-0.1
-0.08
Expected EPS
-0.11361778443000001
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1HM.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.63B
Illumina provides genomic sequencing solutions and competes with Adaptive Biotechnologies in the genomic analysis market.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences offers long-read sequencing technologies that compete with Adaptive's platforms for comprehensive genomic profiling.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with Adaptive's focus on leveraging genetic information for medical solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.58B
Intellia Therapeutics is another key player in the gene editing space, competing with Adaptive in the development of genetically informed therapies.
Editas Medicine
EDIT
Mkt Cap283.93M
Editas Medicine operates in the gene editing industry, directly competing with Adaptive Biotechnologies in the pursuit of personalized medicine solutions.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with Adaptive in the oncology diagnostics market.
Bionano Genomics
BNGO
Mkt Cap13.09M
Bionano Genomics offers genomic analysis tools, competing with Adaptive in the market for genetic research and clinical applications.

About

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Show more...
CEO
Mr. Chad M. Robins M.B.A.
Employees
624
Country
United States
ISIN
US00650F1093

Listings

STU
DE
1HM.STU
MU
DE
1HM.MU
XNAS
US
ADPT
F
DE
1HM.F

0 Comments

Share your thoughts

FAQ

What is Adaptive Biotechnologies stock price today?▼
The current price of 1HM.STU is €11.86 EUR — it has increased by +0.89% in the past 24 hours. Watch Adaptive Biotechnologies stock price performance more closely on the chart.
What is Adaptive Biotechnologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adaptive Biotechnologies stocks are traded under the ticker 1HM.STU.
Is Adaptive Biotechnologies stock price growing?▼
1HM.STU stock has risen by +2.9% compared to the previous week, the month change is a -7.26% fall, over the last year Adaptive Biotechnologies has showed a +49.43% increase.
When is the next Adaptive Biotechnologies earnings date?▼
Adaptive Biotechnologies is going to release the next earnings report on August 05, 2026.
What were Adaptive Biotechnologies earnings last quarter?▼
1HM.STU earnings for the last quarter are -0.11 EUR per share, whereas the estimation was -0.14 EUR resulting in a +18.99% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Adaptive Biotechnologies have?▼
As of May 06, 2026, the company has 624 employees.
In which sector is Adaptive Biotechnologies located?▼
Adaptive Biotechnologies operates in the Health & Wellness sector.
When did Adaptive Biotechnologies complete a stock split?▼
Adaptive Biotechnologies has not had any recent stock splits.
Where is Adaptive Biotechnologies headquartered?▼
Adaptive Biotechnologies is headquartered in Seattle, United States.